Mobic and Thermal burn - a phase IV clinical study of FDA data

Summary:

Thermal burn is reported as a side effect among people who take Mobic (meloxicam), especially for people who are female, 60+ old, also take Hydrochlorothiazide, and have Osteoporosis.

The phase IV clinical study analyzes which people have Thermal burn when taking Mobic. It is created by eHealthMe based on reports of 25,001 people who have side effects when taking Mobic from the FDA, and is updated regularly.

What is Mobic?

Mobic has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 26,684 Mobic users. Check the latest studies of Mobic.

What is Thermal burn?

Thermal burn (burn by heat) is found to be associated with 706 drugs and 787 conditions by eHealthMe. Check the latest studies of Thermal burn.

On Jul, 19, 2026

25,001 people reported to have side effects when taking Mobic.
Among them, 18 people (0.07%) have Thermal burn.

Among these 18 people:

What is the gender of people who have Thermal burn when taking Mobic? *

female: 100 %
male: 0.0 %

What is the age of people who have Thermal burn when taking Mobic? *

What are other drugs people take besides Mobic? *

Ultracet: 8 people, 44.44%
Fosamax: 8 people, 44.44%
Hydrochlorothiazide: 8 people, 44.44%
Enalapril Maleate And Hydrochlorothiazide: 7 people, 38.89%
Metformin: 6 people, 33.33%
Hydroxyzine Hydrochloride: 5 people, 27.78%
Ibuprofen: 5 people, 27.78%
Advair Hfa: 5 people, 27.78%
Colace: 5 people, 27.78%
Cyclobenzaprine Hydrochloride: 5 people, 27.78%

What are other side effects people have besides Thermal burn? *

High Blood Pressure: 10 people, 55.56%
Aseptic Necrosis (the death of bone tissue due to a lack of blood supply): 8 people, 44.44%
Stress And Anxiety: 8 people, 44.44%
Oral Torus (a lesion made of compact bone and occurs along the palate or the mandible inside the mouth): 7 people, 38.89%
Depression: 7 people, 38.89%
Impaired Healing: 7 people, 38.89%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 7 people, 38.89%
Mastication Disorder (disease of chewing food): 7 people, 38.89%
Oral Discomfort (pain or irritation in mouth): 7 people, 38.89%
Oral Pain: 7 people, 38.89%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 7 people, 38.89%
Immunodeficiency Common Variable: 5 people, 27.78%
Asthma: 3 people, 16.67%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 5.56%
Migraine (headache): 1 person, 5.56%
Metabolic Disorder (an abnormal function and pattern of body fat. insulin resistance refers to the diminished ability of cells to respond to the action of insulin in promoting the transport of the sugar glucose, from blood into muscles and other tissues): 1 person, 5.56%
Hypersensitivity: 1 person, 5.56%
High Blood Pressure: 1 person, 5.56%
High Blood Cholesterol: 1 person, 5.56%
Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Mobic and have Thermal burn?

- Check whether Thermal burn is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mobic:

Mobic (26,684 reports)

Thermal burn treatments and more:

Thermal burn (9,161 reports)

Browse all side effects of Mobic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Thermal burn:

Thermal burn (706 drugs)

Browse all the conditions that are associated with Thermal burn:

Thermal burn (787 conditions)

Related publications that referenced our studies

Lai SW, Lin CL, Liao KF, "Association of Meloxicam Use with the Risk of Acute Pancreatitis: A Case–Control Study", Clinical drug investigation, 2015 Oct .
Lai SW, Lin CL, Liao KF, "Association of Meloxicam Use with the Risk of Acute Pancreatitis: A Case–Control Study", Clinical drug investigation, 2015 Oct .

How the study uses the data?

The study uses data from the FDA. It is based on meloxicam (the active ingredients of Mobic) and Mobic (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.